Daniel Sadeh received his bachelor’s degree in 2012 from Queens College of the City University of New York and received his J.D. in 2015 from the Georgetown University Law Center.

Mr. Sadeh joined Bernstein Liebhard in April 2018 and concentrates his practice on securities, commercial, and complex class action litigation.

Mr. Sadeh began his legal career as an attorney at a national law firm representing plaintiffs in securities class actions.  There, he was actively involved in the litigation of numerous securities class actions resulting in substantial recoveries for investors, including:  In re Galena Biopharma, Inc., Securities Litigation, No. 3:14-cv-00367 (D. Or.) ($20 million recovery); Thomas v. Magnachip Semiconductor Corp., et al, No. 3:14-cv-01160 (N.D. Cal.) ($23.5 million recovery); Beck v. Walter Investment Management Corp., et al, No. 1:14-cv-20880 (S.D. Fla.) ($24 million recovery); and In re Montage Technology Group Ltd., Securities Litigation, No. 14-cv-00722 (N.D. Cal.) ($7.25 million recovery).

Mr. Sadeh has also obtained victories on behalf of his clients through precedential judicial opinions on novel areas of law.  In Dartell v. Tibet Pharmaceuticals, Inc. et al, No. 2:14-cv-03620 (D.N.J. Jun 06, 2014), Mr. Sadeh was part of the team that successfully opposed the non-director, “board observer” defendants’ summary judgment motion and obtained a favorable ruling that, despite their lack of voting power, these defendants may be held liable as “persons performing similar functions” to a director under Section 11 of the Securities Act of 1933.

Mr. Sadeh is admitted to practice in the State of New York and the United States District Courts for the Southern and Eastern Districts of New York.

Published April 12, 2018 by